Amoebic gill disease (AGD), caused by Neoparamoeba perurans, is one of the main health challenges for the global Atlantic salmon (Salmo salar Linnaeus, 1758) farming industry (Oldham, Rodger, & Nowak., 2016; Rodger, 2014). This parasite's presence in a number of other marine fish species (Oldham et al., 2016), including cleaner fish species used for the biological control of sea lice in Atlantic salmon farms (Haugland, Olsen, Rønneseth & Andersen, 2017), has resulted in the emergence of new challenges for the industry especially as high mortalities can result if AGD is left untreated (Munday, Zilberg, & Findlay, 2001). Current approaches for controlling AGD are resource-demanding and labour-intensive, involving numerous treatments throughout

No abstract

No abstract

No abstract